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ABSTRACT 
Recent pharmaceutical marketing practices have incorporated more social media tactics 
in the form of unbranded social networking communities to promote, educate, engage, 
and monitor potential consumers. Current attention in this domain has focused mainly on 
regulated tactics such as company-controlled websites, while little attention has been 
given to unregulated communication tools such as social media, where much of the 
interaction is consumer to consumer. The purpose of this research is to test competing 
theories and assumptions of persuasion knowledge activation in a covert brand 
community, specific to the context of pharmaceutical marketing. Researchers and 
practitioners have argued over whether consumers will recognize a persuasion attempt in 
a covert setting, or will not recognize a persuasion attempt in a covert setting, but until 
now there has not been a conclusive answer. The results of this research showed that 
people do not recognize these tactics, either covert or overt, as persuasion attempts; we 
find no significant difference in participants’ evaluations of health and wellness 
communities when branding is present versus when it is absent. This study also shows 
that priming for persuasion knowledge will activate consumers’ persuasion knowledge 
and will result in lower evaluations of perceived trust, and lower intentions to use the 
information in the community. Employing an experimental design, these studies are an 
initial step in the debate on covert marketing’s effects on persuasion knowledge and 
evaluations, specifically in the context of health and wellness communities on social 
media. The results also present interesting opportunities for theory, policy, and practice. 
Keywords: Persuasion Knowledge; Covert Marketing; Covert Brand Community; Social 
Media 
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1. INTRODUCTION 
Pharmaceutical marketing is currently going through an interesting period of transition in 
which many modern marketing tactics are being adopted in the pursuit of consumer 
engagement and brand affinity. Rather than building a presence for a particular brand or 
drug, pharmaceutical companies have started using unbranded social networking 
communities and content marketing to promote disease awareness and patient education. 
Though Canada prohibits most forms of direct to consumer advertising (DTCA), research 
has found that there is an extensive amount of cross border exposure from advertising 
directed to the United States (Law, Majumdar, and Sounerai 2008). However, 
pharmaceutical sites that do not promote a brand or product, but rather provide 
information on medical conditions, are not prohibited in countries that ban DTCA, like 
Canada (Law, Majumdar, and Sounerai 2008). 
 
The use of unbranded pharmaceutical social network communities makes this type of 
marketing covert, as the controlling brand is not necessarily visible to consumers in most 
situations, and does not include the brand names of products or services offered by the 
company. Covert marketing has been defined as marketer-created material, which is 
disguised as impartial non-advertising information (Huh and Shin 2015).  They key 
element in the definition of covert marketing is that the nature of the message, and/or 
source of the message, is disguised, hidden or not directly acknowledged when 
communicated to the consumer (Akdogan and Altuntas 2015; Milne, Bahl, and Rohm 
2008). This area within marketing is intriguing because the recent research has had 
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trouble keeping up with the strategies that are being adopted in practice. Some academics 
have categorized this type of marketing as deceptive because it impedes consumers’ 
ability to clearly recognise an advertisement and its sponsor (Wojdynski, Evans, and Hoy 
2017). The U.S. Federal Trade Commission (FTC) considers a communication attempt to 
be deceptive “if [advertisers] mislead consumers into believing they are independent, 
impartial, or not from the sponsoring advertiser itself” (FTC 2015). 
 
Covert marketing tactics have been proposed by Fransen, Verlegh, Kirmani, and Smit 
(2014) as a way for overcoming consumer advertising resistance strategies in order to 
prevent the activation of persuasion knowledge. They suggest that to prevent neutralizing 
or avoidance responses from consumers, marketers should disguise the “persuasive intent 
or sender of the message” (p 11). This is currently being done by pharmaceutical 
marketers through the promotion of content as help giving and educational material, by 
sharing content created by community members, and also by masking the pharmaceutical 
organization controlling the community. This content is often created by sponsored 
bloggers, members of the community, or by the pharmaceutical company itself.  These 
tactics feature no, or very minimal, branding cues that indicate a particular company’s 
involvement.  
 
This form of covert communication shares many similarities with other tactics, such as 
sponsored content, also known as native advertising. However, as Wojdynski and Evans 
(2015) explain, native advertising is “any paid advertising that takes the specific form and 
appearance of editorial content from the publisher itself” (p 1). In addition to native 
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advertising, other ways in which marketers have used covert communications to work 
around consumer resistance to advertising messages is product placement (Campbell, 
Mohr, and Verlegh 2013). Campbell, Mohr, and Verlegh (2013) suggest that “placing 
products in entertainment or sponsoring bloggers” (p 483) is a way for marketers to 
“avoid activating consumers’ persuasion knowledge and scepticism” (p 483). When 
marketing messages are presented to a consumer in an entertainment context—such as 
covert online communities, product placement, or native advertising—it has been 
presumed that these attempts will be interpreted by consumers as entertainment, and 
therefore it will not activate their marketplace related knowledge (Cowley and Barron 
2008). Though product placement pre-dates native advertising and content marketing, it 
relates to these covert online communities because the source of the communication 
attempt is obscured (Campbell, Mohr, and Verlegh 2013).  
 
In covert online communities, brands are sharing their own content as well as 
encouraging opinion leaders and influencers to share content in the community where the 
source or sponsor of the message is not clearly stated, giving the impression that it is un-
sponsored non-marketing material. Right now, much of the research has been focused on 
the branded health information sites and consumer responses toward them (Huh and Shin 
2015; Johnson and Lowe 2015). 
 
1.1 BACKGROUND 
DTCA, which is currently legal only in the USA and New Zealand, is one of the most 
controversial topics in modern business (Liang and Mackey 2011; Scott Rader, Subhan, 
 4 
Lanier, Brooksbank, Yankah, and Spears 2013) and one of the largest categories of 
advertising spending in the USA (Delbaere and Willis 2016; Law, Majumdar, and 
Sounerai 2008; Liang and Mackey 2011). Regulatory bodies, like the Food and Drug 
Administration (FDA) in the U.S., influence what drug companies can say over print and 
broadcast media to ensure promotional statements do not make claims that overstate 
benefits or understate risks involved in drug treatments (Scott Rader et al 2013).  
 
The FDA (2015) has permitted three main types of drug advertisements in the USA and 
has specific content requirements for each type. The first type of ads are called “Product 
Claims Advertisements”, which explicitly name a drug and communicate its benefits and 
risks. These ads cannot be misleading, and the benefits and risks need to be presented in a 
“balanced fashion” (FDA 2015). The next type of ads are “Reminder Advertisements”; 
this type of ad assumes the audience knows of the drug and its uses, and therefore only 
names the drug. A reminder ad does not need to disclose risks, and therefore cannot 
suggest its uses or benefits (FDA 2015). The last type of ad is a “Help-Seeking 
Advertisement”, this type of ad describes a disease or condition, but does not make 
specific drug treatment recommendations (FDA 2015). A help-seeking ad can also 
include a drug company’s name (FDA 2015). Interestingly, the FDA states, “when done 
properly, help-seeking ads are not considered to be drug ads. Therefore we do not 
regulate them…” (FDA 2015). 
 
Recently, DTCA has evolved with the rise in new forms of technology and 
communication; this technology has allowed consumers to become “more active in the 
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provision of their health care” (Scott Rader et al 2013, p 196) online. With the rise of 
health and drug information and promotion online, DTCA has become more global as 
information freely crosses borders through the Internet, which is an issue for many 
regulatory bodies (Law, Majumdar, and Sounerai 2008; Liang and Mackey 2011). 
Research by Law, Majumdar, and Sounerai (2008) showed that, though the impact of 
DTCA is “highly variable”, cross-border exposure to DTCA from the U.S. to Canada has 
influenced prescribing rates in some cases. 
 
The evolution of electronic DTCA (eDTCA) has presented an interesting scenario for 
pharmaceutical marketing and regulatory bodies. Pharmaceutical companies are moving 
away from their own regulated drug information sites, and moving towards general health 
information sites, blogs, social networking sites, and online communities where 
ownership is unclear (Scott Rader et al 2013). This grey-area has caused trouble for the 
FDA, as little, or no, explicit cues of ownership are present on these sites. As Huh and 
Shin (2015) highlight, without clear indication of a pharmaceutical company’s 
involvement “such company-sponsored disease information websites are not considered 
advertising and, thus, not subject to the FDA regulation for DTC prescription drug 
advertising” (p 308).  
 
Pharmaceutical marketers are adopting practices and tactics that are not typically 
associated with the health care industry, and these tactics and their effectiveness have not 
been adequately research by marketing academia. As seen in the e-book published in 
2015 by Medical Marketing and Media, titled The Healthcare Brand Manager’s Guide to 
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Content Marketing, pharmaceutical advertisers are being guided on how best to utilize 
content marketing on social media and how it can be integrated into pharmaceutical 
campaigns. Rather than pushing information on their prescription drugs, pharmaceutical 
advertisers are shifting the focus to emphasize educational content that engages their 
consumers.  
 
Companies do not mention specific treatment on social media, but rather focus on the 
disease or medical condition. For example, Pfizer has set up a health and wellness 
community group on Facebook called Quitter’s Circle. This page shares information, tips, 
and support on quitting smoking but never overtly promotes a prescribed method of 
treatment. Pfizer is rarely mentioned on the page and there is also no mention of its drug 
Chantix, which is the leading prescribed medication for quitting smoking. This practice 
of keeping the brand covert when setting up health and wellness communities is 
becoming a popular tactic for industry leaders in the pharmaceutical sector.  
 
Scott Rader et al (2013) suggested that pharmaceutical companies are not keeping up 
with the “unprecedented shift towards consumer empowerment” (p 211); they propose 
that pharmaceutical advertisers should begin to listen to and monitor consumers online 
using social media and keyword searches, and then analyze the results. Their initial 
suggestion was a passive means of tracking consumer-to-consumer conversations online 
by monitoring a brand’s presence online, versus actively engaging with consumers 
online.  
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Scott Rader et al (2013) also proposed that beyond monitoring their brand’s presence 
online, there is an opportunity for pharmaceutical advertisers to “link extant web-related 
marketing efforts in the form of disease education to the highly active and increasingly 
popular social media platforms where consumer bonding occurs” (215). Rather than just 
observing the conversations, pharmaceutical marketers are covertly engaging with 
consumers under the guise of unbranded online communities and wellness groups. The 
covert aspect of this communication is important because, as explained by Wojdynski, 
Evans, and Hoy (2017), the degree to which a sponsor and an advertisement are 
recognized as such can have an impact on consumer attitudes. 
 
Scott Rader et al’s (2013) Interaction Model (see Figure 1.1) is a clear and concise 
representation of the current online landscape of pharmaceutical marketing, and is 
presented as a constellation of outlets that are linked together by pharmaceutical 
companies. This unique form of communication allows pharmaceutical companies to 
navigate constraints by passing nonspecific disease education information through social 
media, promoting consumer bonding (Scott Rader et al 2013). 
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Figure 1.1 
Interaction Model (Scott Rader et al 2013)
 
 
This Interaction model is also an accurate representation of where academic research has 
been focused. Currently, research has focused on the areas of healthcare education 
websites, and drug information websites (Huh and Shin 2015; Johnson and Lowe 2015). 
This was valuable to better understand these online pharmaceutical marketing methods, 
but little has been done to explore the online social network health and wellness 
communities, which is the focus of this research. As Rotfeld (2008) explains, much of the 
covert marketing undertaken by professionals is done with a great amount of uncertainty 
of whether it really works; this research will be a much needed first step into the 
effectiveness of these covert marketing attempts. 
 
1.2 COVERT BRAND COMMUNITIES 
The online health and wellness communities that pharmaceutical companies are creating 
and managing are the focus of this research, in part because they have been largely 
overlooked by much of the online pharmaceutical marketing research. Though these 
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communities use covert tactics that often keep the parent pharmaceutical brand hidden, 
they do resemble conventional brand communities.  These covert brand communities are 
specialized groups, with participants that are non-geographically bound and have a shared 
consciousness with unique rituals and traditions (McAlexander, Schouten, and Koenig 
2002; Muniz and O’Guinn 2001).  
 
A marketplace ritual is defined as “a planned, symbolic, performative and often repeated 
activity that providers execute for and with customers, to enhance customer experiences 
and achieve marketing goals” (Otnes, Ilhan, and Kulkarni 2012, p 367). Examples of 
unique rituals and traditions in these covert brand communities include things such as 
providing members of a Type II diabetes community—America’s Diabetes Challenge—
with healthy recipes and alternatives around holidays that involve eating. Another 
example is during high stress holidays, reminding members of a quitting smoking 
community—Quitter’s Circle—of their original motivation for quitting to keep them on 
track during high stress periods and encouraging members to share their stories when 
they have reached a milestone. Otnes, Ilhan, and Kulkarni (2012) have highlighted that 
topics such as holidays, and life passages, especially from a consumer’s perspective, are 
important subjects within marketplace rituals. The main difference is that these groups 
focus on a covert service or idea rather than a branded one. These covert online 
communities present an interesting consumption scenario for branding research as well.  
 
These communities are made up of members that share common experiences, seek 
information, and participate and interact of their own will. In these groups members share 
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and consume knowledge and experience to improve the well being of other members and 
themselves (Johnson and Lowe 2015). The social sharing and consuming of similar ideas 
and information adds to the common goals and consciousness that build brand 
communities (Johnson and Lowe 2015; Muniz and O’Guinn 2001).  
 
As highlighted by Johnson and Lowe (2015), another aspect of these online communities 
is that they serve an important functional benefit to members that goes beyond the social 
benefits of the group. The functional benefits that these groups offer are vital to the 
pharmaceutical company that runs the pages, because they include things like health 
related learning, understanding the disease and symptoms, and potential solutions. These 
functional benefits do not only happen when the organization communicates with the 
consumers, this also happens when consumers communicate their experiences and 
expertise with each other (Johnson and Lowe 2015). As seen in the 2016 article from 
branchannel by Nicole Diamant, people in these communities weren’t “just looking for 
content—they were looking for people with similar experiences”. 
 
An important factor in these strategies, as mentioned, is that these pages focus on 
promoting educational content and disease awareness in an unbranded setting, often 
partnering with 3rd party advocacy groups or established support organizations. Though 
co-branding attempts and brand alliances can result in both positive and negative 
evaluations (Cunha, Forehand, and Angle 2015; James 2005), partnering with a category 
relevant 3rd party advocacy group would most likely result in stronger positive 
associations towards the covert brand community. Simonin and Ruth (1998) show that 
 11 
this is due to potential “spillover effects” of positive associations towards the 3rd party 
group, onto both the covert brand community and the partnering pharmaceutical brand. In 
addition, when viewing this type of marketing content, peoples’ persuasion knowledge is 
not necessarily activated because they are likely to be in a casual and unconstrained 
mental state when an “ulterior motive is not highly accessible” (Campbell and Kirmani 
2000, p 72). Another tactic that is used is the recruitment of opinion leaders who share 
their content. This is another relevant point with regards to persuasion knowledge 
activation, because messages received by peers may not be perceived as persuasion 
attempts (Chu and Kim 2011).  
 
1.3 PERSUASION KNOWLEDGE MODEL 
The Persuasion Knowledge Model (PKM) has an important role in this research. The 
PKM proposes that “consumers develop knowledge about persuasion and others’ 
persuasion attempts and delineates how people develop and use this knowledge” 
(Campbell and Kirmani 2008, p 551). This model addresses a consumer’s knowledge 
about persuasion attempts, and how they react in order to achieve their own goals 
(Campbell and Kirmani 2008; Friestad and Wright 1994; Friestad and Wright 1999; 
Wright 1986; Ham, Nelson, and Das 2015). A person’s persuasion knowledge (PK) 
develops and changes over time with more marketplace experience and information, and 
can be a way for consumers to recognize, interpret, and respond to advertisements or 
marketer’s attempts to persuade (Huh and Shin 2015). Friestad and Wright (1994) further 
clarify that the effects of persuasion knowledge activation can be either positive or 
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negative, and that a persuasion attempt can be anything “designed to influence someone's 
beliefs, attitudes, decisions, or actions” (p 2).  
 
Persuasion knowledge has a very broad scope and many factors play important roles in 
the interaction between a “persuasion target” and “persuasion agent”. These factors 
include beliefs about a marketer’s persuasion goals, beliefs about persuasion tactics, and 
one’s own coping behaviours (Campbell and Kirmani 1994; Ham, Nelson, and Das 
2015). PK has been described as multi-dimensional and context specific, as there are 
many different ways to measure and activate someone’s PK (Ham, Nelson, and Das 
2015). Past research has shown that covert persuasion attempts can result in positive 
evaluations when perceived as appropriate (Isaac and Grayson 2016; Wei, Fischer, and 
Main 2008). The key factor of importance in covert marketing is that when viewing a 
covert persuasion attempt, consumers may not pick up on important cues that inform 
them of the true intent of the persuasion attempt (Wojdynski, Evans, and Hoy 2017).  
 
As Campbell and Kirmani (2008) have explained, belief and suspicion of motives is an 
important part of PK, and in the context of covert marketing, research has yet to show if 
sponsorship cues in a covert setting will activate suspicion and PK or evade PK 
activation. Recent research in advertising and product placement (Cowley and Barron 
2008; Isaac and Grayson 2016) has also assumed priming for suspicion of ulterior 
motives will result in differences in evaluations, but have yet to show its relationship with 
PK activation through research. This is important because by only showing that priming 
people for suspicion of ulterior motives will result in different evaluations, it cannot be 
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said conclusively that it is PK that influences this relationship, or that this effect is the 
result of a person’s PK being activated. This assumption accepts an important 
relationship between PK activation and outcome variables that has yet to be shown in 
research. 
 
1.4 RESEARCH QUESTIONS 
The driving theory behind this research is persuasion knowledge—including marketplace 
metacognition (Campbell and Kirmani 2000; Campbell and Kirmani 2008; Friestad and 
Wright 1994; Fransen et al 2015; Ham, Nelson, and Das 2015; Wright 1986; Wright 
2002). PK research on covert tactics where the transparency of an advertising sponsor is 
less clear (Wojdynsky, Evans, and Hoy 2017) such as native advertising (Wojdynsky and 
Evans 2015) and product placement (Cowley and Barron 2008; Campbell, Mohr, and 
Verlegh 2013; Wei, Fischer, and Main 2008) has provided a good starting point for 
investigating this new type of covert tactic. The context of this research is within 
pharmaceutical marketing online, where there is a clear disconnect between the tactics 
that are being practiced in industry, and research that has been conducted. This leads to 
the primary research questions: 
A. Is persuasion knowledge activated in a covert brand community? 
B. Does activating persuasion knowledge influence member evaluations of, and 
intentions to use, information in Facebook health and wellness communities? 
Answering these research questions is important for both practice and academia because 
it requires testing competing ideas, common assumptions, and analyzing tactics that have 
not previously been researched. Because consumers are now more active in their search 
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for online health information (Huh and Shin 2015), it is important that we research the 
ways companies are trying to persuade potential consumers online, and if their new 
tactics work as assumed. In the domain of pharmaceutical covert brand communities, we 
do not yet know of the relationship between persuasion knowledge activation and its 
effect on evaluations. Therefore, we cannot say if this tactic can be used to avoid a 
consumer’s persuasion resistance coping behaviours, or if this tactic will be judged as 
appropriate and result in positive evaluations.  
 
The use of this tactic in the pharmaceutical domain is also an area of policy that is not 
clearly defined. This is because the focus of these communities is on help seeking and 
disease awareness, which when done properly, are less restrictive (FDA 2015; Huh and 
Shin 2015). Without knowing how these tactics work, it can be hard to speculate how 
policy can adapt to these new tools online (Milne, Bahl, and Rohm 2008). Additionally, 
with the use of any covert tactic there is an ethical dimension that needs to be considered 
by marketers when intentionally omitting important information that could influence 
consumers’ evaluations and behaviours. As Wojdynski, Evans, and Hoy (2017) explain, 
consumers’ existing guides for interpreting advertisements may not function effectively 
in the context of covert marketing attempts versus when consumers evaluate traditional 
advertising; thus, more research is needed on this covert tactic. 
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2. STUDY 1 
2.1 BACKGROUND 
Research on persuasion knowledge in the area of covert and deceptive marketing has not 
shown conclusive evidence that PK will be activated in an online setting. Some research 
points to the fact that PK should be activated because suspicion of ulterior motives will 
be triggered by the presence of marketing stimuli or cues (Campbell and Kirmani 2008; 
Cowley and Barron 2008; Wei, Fischer, and Main 2008). Research also shows that when 
cognitive capacity is unconstrained, as when casually viewing social media, there is a 
higher likelihood of PK activation (Campbell and Kirmani 2008; Friedstad and Wright 
1994; Main, Dahl, and Darke 2007). Huh and Shin (2015) highlight the importance of 
questioning whether ownership information would change consumers’ evaluation and 
responses to sponsored information, further saying that they thought it likely would.  
 
Other research points to that fact that the covert nature of the unbranded communities is 
designed to prevent PK from being activated (Campbell, Mohr, and Verlegh 2013; 
Fransen et al 2015; Laran, Dalton, and Andrade 2011), and that presenting consumers 
with a persuasion stimulus in an entertainment context will evade PK activation (Cowley 
and Barron 2008). Industry professionals have admitted that they use these tactics in 
order to promote disease awareness, and gain brand affinity, especially when their 
company is the market leader. In these cases, it has been acknowledged that disease 
promotion would eventually lead to increased sales (Huh and Shin 2015). 
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Much of the earlier attention in the online pharmaceutical domain has focused on 
company controlled communication such as corporate web portals, and drug information 
sites—which are both regulated—leaving an important and growing area of research 
focusing on tools such as social media that play an important role in consumer to 
consumer interaction (Scott Rader et al 2013; Tyrawski and DeAndrea 2015). With that 
in mind, Rotfeld (2008) explains that most covert efforts are undertaken with great 
uncertainty, and more research is needed to see whether these tactics will activate PK, or 
evade PK activation. Therefore, no hypotheses were developed for this study, as the goal 
is to test two competing ideas by addressing the following question: Is persuasion 
knowledge activated in a covert brand community? 
 
2.2 METHODOLOGY 
An experiment with a 3 (brand community: branded vs. unbranded vs. 3rd party) x 2 
(chronic disease: multiple sclerosis ‘MS’ vs. Type 2 diabetes) between-subjects design 
was conducted to answer our research question. Participants were undergraduate students 
from a large North American university. Study one was reviewed and approved on ethical 
grounds by the Behavioural Ethics Research Board at the University of Saskatchewan 
(See Appendix A). 
 
We chose two chronic diseases as the context for this research because these diseases 
have a greater daily impact and are more central to peoples’ lives than many other 
medical conditions; as a result, people who suffer from chronic diseases often share and 
bond with others who are experiencing similar conditions (Huh and Shin 2015). All 
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participants read a scenario in which they were asked to imagine they had been recently 
diagnosed with a chronic disease and were members of an online community. We 
selected MS and Type II diabetes as the diseases for this study because of their 
prevalence in our geographic region, the fact that both diseases are treated with 
prescription medication, and that each disease had a popular online community sponsored 
by a large pharmaceutical company. We chose to include two types of chronic illnesses to 
control for any effects that a specific illness might have on consumers’ perceptions of the 
communities. After reading the scenario, participants viewed screen shots of an actual 
Covert Brand Community on Facebook that had been modified to represent our 
experimental conditions. We used actual posts and comments from an online MS 
community sponsored by Novartis, and an online diabetes community sponsored by 
Merck (See Appendix E for scenario and Appendix F, G, and H for stimuli). 
 
To ensure equivalency we edited the screen shots so that the Facebook pages had the 
same number of likes, the posts had the same number of comments, and the pages in the 
branded condition included the logo from the same pharmaceutical company 
(GlaxoSmithKline). We used the logos from the Multiple Sclerosis Society and the 
American Diabetes Association for the 3rd-party condition. A post exposure questionnaire 
was administered to participants after reading the scenario and the stimuli. As Ham, 
Nelson, and Das (2015) explain, there are many different and effective ways to research 
and measure persuasion knowledge. Like much of the research on persuasion knowledge, 
the measurements that were chosen focus on the differences in a target’s evaluation of a 
persuasion attempt.  
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Because the nature of PK is complex and context specific, multiple scales were adapted 
and used to measure PK, as recommended by Ham, Nelson, and Das (2015). Persuasion 
Knowledge Activation was measured using two multi-item scales adapted from Campbell 
and Kirmani (2000) and Wang et al (2008), and two open-ended response questions also 
adapted from Campbell and Kirmani (2000). Campbell and Kirmani’s (2000) scale 
measured perceived sincerity by using an average of four seven point semantic 
differential items: sincere/insincere, honest/dishonest, not manipulative/manipulative, and 
not pushy/pushy and formed our first measure of PK activation (Appendix I Question 3). 
The second PK activation measure was adapted from Wang et al’s (2008) agreement 
statements which measured participants’ attitudes towards important dimensions of 
persuasion knowledge on a 7-point agreement scale: information accuracy, information 
trustworthiness, and perceived influence (Appendix I Question 4a-d). We included a 
measure of credibility because it has been identified as an important factor in health 
information and Internet groups. Perceived Website Trust was also measured using a 7-
point agreement scale adapted from Huh and Shin (2015) (Appendix I Questions 5-11). 
 
Using the thought-listing measure adapted from Campbell and Kirmani (2000) (Appendix 
I Questions 1 and 2), participants were asked to write down what they were thinking 
when viewing the Facebook community; these open-ended responses were then coded for 
suspicious thoughts. Suspicious thoughts included any thoughts indicating suspicion 
about aspects of the stimuli, such as motives, ulterior intent, the source of the community, 
or the content on the community page. The proportion of suspicious thoughts was 
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analyzed in relation to the total thoughts that were listed, and used as another measure of 
persuasion knowledge activation (Campbell and Kirmani 2000). 
 
2.3 RESULTS 
A total of 183 students voluntarily participated in the study ranging in age from 18 to 30 
years old (Mage = 20.41, 52.7% female, 3.6% preferred not to say) recruited from an 
introductory marketing course. Students were randomly assigned to a condition, and each 
condition had a minimum of 29 participants to ensure adequate power for the analyses. 
There were 90 respondents in the MS condition (NMS = 90) and 93 respondents in the 
diabetes condition (N Diabetes = 93). There were 61 respondents in the logo condition (N 
Logo = 61), 60 respondents in the no logo condition (N No Logo = 60), and 62 respondents in 
the 3rd party condition (N 3rd Party = 62). Our analysis revealed that 82.4% of all 
respondents indicated that they had gone online to look up health-related information. 
The top identified sites for referencing health information online were Google (29.2%), 
WebMD (20.8%), and Health Canada (20.6%). Facebook was well below, being 
identified as a health information reference by only 4.3% of respondents. 
 
When asked about the purpose of the Facebook group, 34.5% of respondents viewed the 
group’s primary purpose as member support, 32% stated that the group’s purpose was for 
health promotion/education, and 27.5% of people stated that the purpose of the group was 
for connecting people and sharing information about the disease. Only 4.7% of people 
thought the purpose of this group was related to pharmaceutical promotion and/or market 
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research. There were no significant differences in how people viewed the purpose of the 
community between both logo and disease conditions (p > 0.05). 
 
To check our logo manipulation participants were asked if they recalled seeing a logo on 
the page. In the branded condition, significantly more participants recalled having seen a 
logo than not (69%; p = 0.006). In the 3rd party condition slightly more people recalled 
seeing a logo than not; however, the difference was non-significant (yes = 57%, no = 
43%; p = 0.341). In the unbranded condition, there were no significant differences 
between the percentage of participants who recalled seeing a logo versus not (yes = 44%, 
no = 56%; p = 0.488). If participants indicated that they recalled seeing a logo, we asked 
them to indicate which logo. While there were no significant differences, several 
participants in the unbranded condition indicated having seen either the Facebook logo or 
the name of the Facebook page, both of which were present on the screen shot. This 
could explain why so many participants in the unbranded condition recalled having seen 
a logo. Given that none of these participants indicated that they recalled having seen a 
pharmaceutical company logo, we believe this is evidence of a successful manipulation.   
 
Two independent coders analyzed the thought listings from all participants. A total of 517 
thoughts were coded as either suspicious, not suspicious, or not relevant (M Thoughts/Person = 
2.83). Suspicious thoughts included thoughts such as: “posts felt like sponsored ads” and 
“helpful links posted; but are they credible?”, and not suspicious thoughts included 
thoughts such as: “It's nice to belong to a group where I can relate with other people” and 
“I feel a sense of community”. All disagreements were resolved through discussion. 
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Cohen’s Kappa was calculated to determine inter-rater reliability and revealed a high 
level of inter-rater reliability (κ = 0.87). The analysis revealed there was no significant 
difference in the number of suspicious thoughts across all conditions (M Logo = 0.76, 
MNoLogo = 0.81, M3rd Party = 0.76; p > 0.05).  
 
A scale reliability analysis was conducted to ensure each item in the questionnaire 
sufficiently measured what it was intended to measure. Cronbach’s Alpha for the first PK 
measure (α = 0.727) showed that each item in the scale did an adequate job of measuring 
what was intended; therefore we can further analyze PK using this measure. Our scale 
reliability analysis of the second PK measure yielded a Cronbach’s Alpha of α = 0.682 
revealing that the scale was not an accurate measure for PK. Further analysis showed that 
the item measuring “perceived influence” was very low on inter-item correlation and the 
adjusted Cronbach’s Alpha if that item was deleted increases to α = 0.842. Therefore, in 
the analysis of our second PK measure, the “perceived influence” item was removed. The 
scale reliability analysis of perceived website trust showed a high level of accuracy in the 
scale measurements (α = 0.876), meaning that we will use this total measure when 
analyzing perceived website trust. 
 
Levene’s test for our scale item measures revealed the assumption of homogeneity of 
variances was not violated (p > 0.05). To test for the assumption of normality the 
Kolmogorov-Smirnov test was used for each scale measure between the logo conditions. 
The second PK measure and the measure for perceived website trust did not violate the 
assumption of normality (p > 0.05). The Kolmogorov-Smirnov test for the first PK 
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measure revealed a violation in this assumption (p < 0.05); however, because parametric 
tests are fairly robust against minor failures of non-normality, the sample size was large, 
group sizes were relatively equal, and a visual inspection of the Q-Q plots showed only 
slight deviations in the graph, this violation in normality was ignored and parametric tests 
were used in all cases (Field 2013; Marshall n.d.). 
 
Our results showed no significant differences between disease conditions on any of our 
measures (p > 0.05) and therefore the disease conditions were combined for the rest of 
the analyses. Our analysis found no significant differences between any of the conditions 
for all PK activation measures (p > 0.05). A measure of perceived website trust (adapted 
from Huh and Shin 2015) similarly showed that the presence of a pharmaceutical 
company logo did not influence participants’ perceptions of the trustworthiness of the 
Facebook community and the information on it (p > 0.05). This study shows that 
persuasion knowledge is not necessarily activated in a covert brand community in a 
health context (See Table 2.1). 
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Table 2.1  
Descriptive Statistics for PK activation (measure 1) and Perceived Website Trust 
Disease Cond. Logo Cond. Mean (PK 1) 
SD 
(PK 1) 
Mean 
(Perceived Trust) 
SD 
(Perceived Trust) 
Logo 5.20 1.12 4.30 1.09 
No Logo 5.32 1.12 4.30 1.21 
Third Party 5.40 .81 4.00 .97 
Logo 5.05 1.09 4.12 1.08 
No Logo 5.06 1.11 4.31 1.10 
Third Party 5.03 .95 4.27 .97 
Logo 5.13 1.10 4.21 1.08 
No Logo 5.18 1.11 4.30 1.15 
Third Party 5.21 .90 4.14 .97 
 
We found that consumer attitudes did not differ significantly when pharmaceutical 
branding was present versus absent. This result lends support to the argument that 
consumers do not view these covert brand communities as persuasion attempts, as some 
academics (Fransen et al 2015; Laran, Dalton, and Andrade 2011) and industry 
professionals have speculated. Very similar to the results of Wojdynski and Evans’ 
(2015) study on native advertising, which found that most people did not recognize the 
sponsored content as advertising, these covert persuasion attempts in brand communities 
appear to go largely unnoticed by consumers. They also do not result in the typically 
sceptical outcomes of PK activation, which, in the context of pharmaceutical marketing, 
has important ethical and policy implications. 
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2.4 DISCUSSION  
Though some researchers have thought that consumers have the ability to recognize and 
correct for covert persuasion attempts, our results show that this covert persuasion 
attempt is not being recognized. This result adds legitimacy to the concern that covert 
marketing tactics will go undetected and can be used as a way to avoid PK activation, 
which has been speculated by industry professionals and some researchers. The objective 
of this research was to address the debate on PK activation in a covert setting, which until 
now had not produced a conclusive answer.  
 
3. FOLLOW-UP STUDY 
In order to address two of the alternative explanations in our first study, a follow-up study 
was conducted in an extension of the first study. Using only one disease condition and an 
older sample population, two sets of brand community stimuli were created; one with 
GlaxoSmithKline branding cues from study 1, and the other with Pfizer branding cues. 
The goal of this study was to see if an older population would have different perceptions 
of covert brand communities, and if the presence of an alternative pharmaceutical 
brand—Pfizer—would influence people’s evaluations of the community. 
 
Our follow up study had 30 participants ranging in age from 21 to 55, (M age = 36.38). 
53% of participants were female, 43% were male. In order to test if more participants 
recalled seeing a logo in each condition, Fisher’s exact test was conducted to test for 
significant differences between categorical groups (Field 2013). This test found that 
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significantly more people recalled seeing a logo in the Pfizer condition (86.7%) than in 
the GlaxoSmithKline condition (50%) (p = 0.05). Of the people who recalled seeing a 
logo in the Facebook group, and correctly identified the organization’s logo, there were 
no significant differences in familiarity of the organization between groups (M Pfizer = 4.1, 
M GSK = 2.0, p = 0.166).  
 
This study found that on average, participants were more skeptical of the Facebook 
community when Pfizer's branding was present (M Pfizer = 3.68, SD Pfizer = 1.25), versus 
when GSK's branding was present (M GSK = 4.68, SD GSK = 1.34). This difference (MD = -
1, 95% CI [0.02973, 1.9727], was significant t(28) = 2.11 (p = 0.044). This could be 
because more people recalled seeing a logo in the Pfizer condition, and so their 
persuasion knowledge towards the Facebook group was activated resulting in lower 
evaluations, which is indicative of higher skepticism. 
 
Several findings from study 1 and the follow-up study were used to inform study 2. First, 
because the first study found no significant differences between disease conditions (p > 
0.05), the subsequent study focused on one chronic illness condition. Next, with no 
differences in the 3rd party branding condition (p > 0.05), though an interesting avenue 
for future research, this condition was dropped for the following study. Lastly, as a result 
of the follow-up study, the next study uses branding cues from Pfizer rather than GSK, as 
more people recalled the Pfizer logo in that condition. 
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4. STUDY 2 
4.1 BACKGROUND 
The purpose of study 2 is to answer the second research question: Does activating 
persuasion knowledge influence member evaluations of, and intentions to use, 
information in Facebook health and wellness communities? Thus, the objective of study 2 
is to analyze peoples’ PK activation, evaluations, and behavioural intentions when 
viewing a Covert Brand Community after being primed for PK. This study extends the 
findings of study 1, addresses some of the limitations of study 1, and incorporates 
components from recent research. Analyzing evaluations such as perceived website trust, 
attitude towards Pfizer, and behavioural intentions will produce practical insights into the 
effectiveness of these strategies. 
 
Recent research has shown that priming consumers to consider the appropriateness of 
persuasion attempts can result in positive evaluations. This is a departure from most 
research on persuasion knowledge, which has largely found negative evaluations as a 
result of priming. What most studies of persuasion knowledge have in common, however, 
is that once they confirm that a prime activates persuasion knowledge in a pre-test, they 
typically do not test for activation in subsequent studies. A goal for study 2 is to include a 
measure of PK activation in our model and test its effect as a mediator on evaluations and 
behavioural intentions. Another important relationship tested in study 2 is whether or not 
branding cues will moderate the relationship between PK activation and evaluations and 
intentions. According to the results of Isaac and Grayson (2016), when consumers were 
 27 
primed to consider the appropriateness of persuasion attempts, and were then exposed to 
a credible persuasion tactic, there was a positive impact on evaluations. By making 
consumers aware of the existence of covert health and wellness communities on social 
media, and then exposing them to a community that displays the sponsoring brand, we 
believe that there could also be a positive influence on evaluations and intentions. We 
therefore hypothesize that: 
 
H1:  When PK is activated and Pfizer’s branding is present, participants will have 
higher evaluations as well as greater intent to use the information versus when PK 
is activated and no branding is present.  
 
H2:  When PK is not activated and when Pfizer’s branding is present, we expect there 
to be lower evaluations and lower intent to use information versus when branding 
is present and PK is activated.  
 
We expect that PK activation, paired with Pfizer’s branding, will result in higher 
evaluations because research has found that when participants perceive a tactic as 
appropriate and have higher brand familiarity they will have greater evaluations (Wei, 
Fischer, and Main 2008). Because we found that more participants recognized Pfizer 
rather than GSK, we expect more people to notice Pfizer’s branding. Thus, when a 
participant’s PK is activated, rather than having negative evaluations, we would expect 
people to recognize the branding cues and consider the tactic appropriate because they 
would expect a pharmaceutical brand to be marketing disease awareness, and therefore 
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have higher evaluations. However, when participants are not primed to be aware of a 
persuasion attempt, we expect the presence of Pfizer’s branding to be judged as 
inappropriate, and result in lower evaluations versus when their PK is activated. 
 
H3:  When PK is not activated, we expect there to be no difference between logo 
conditions. 
 
Similar to the findings of out first study, we hypothesize that when PK is not activated, 
we will find no differences in participants’ evaluations or behavioural intentions between 
the logo conditions. 
Figure 4.1 
Hypothesized Model 
 
 
4.2 METHODOLOGY 
Study 2 is designed as a 2 (Logo vs. No Logo) x 2 (PK Prime vs. No Prime) between 
subjects experiment design. Because our first study found no significant differences 
between disease conditions, our second study focused on only one chronic illness, Type 
II diabetes. This study also dropped the 3rd party condition as no differences were found 
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in the first study. The Social Sciences Research Laboratories (SSRL) at the University of 
Saskatchewan recruited participants online from across Canada using a research panel 
from Ekos. Ekos recruits participants using random digit dialling; once recruited, they are 
added to Ekos’ research panel and are contacted when a research opportunity is made 
available. All participation was voluntary, and the participants were not compensated.  
The University of Saskatchewan once again approved the study on ethical grounds (See 
Appendix B). 
 
Once again participants read a scenario, however this time the scenario either included a 
prime for PK or no prime. Isaac and Grayson’s (2016) research provided a starting point 
for developing a prime. Upon further consultation with additional experts, a neutral prime 
was developed to ensure the prime would not produce demand effects (See Appendix M). 
Participants then viewed screenshots of a covert brand community on Facebook similar to 
the ones used in study 1. For study 2 we decided to use the pharmaceutical brand Pfizer 
rather than GSK as more people noticed it in our follow-up study. As with our first study, 
to ensure equivalency, both versions of the Facebook group had the same wall posts, 
same number of likes, and same comments. The only difference between conditions was 
the presence of Pfizer’s branding. In this study, the Facebook group was an altered 
version of Merck’s community—America’s Diabetes Challenge, however all Merck 
branding was either removed or replaced with Pfizer’s depending on the condition. We 
also altered and re-named the group to Diabetes Challenge in order to reflect the 
Canadian population that would be surveyed. 
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Our second study used the same two multi-item scales from the first study to measure PK 
activation: Campbell and Kirmani’s (2000) perceived sincerity scale (Appendix P 
Question 3) and an adapted version of Wang et al’s (2008) agreement statements 
measuring participants’ attitudes (Appendix P Question 4a-d). Additionally, the same two 
open ended questions adapted from Campbell and Kirmani (2000) were used again as 
well (Appendix P Questions 1 and 2). Huh and Shin’s (2014) agreement scale on 
perceived website trust was once again used (Appendix P Questions 5-11), and Huh and 
Shin’s (2014) agreement scale on intent to use information was also added in order to 
measure the dependent variables of perceived trust and behavioural intentions (Appendix 
P Question 12 i-vi). 
 
When dealing with chronic illnesses, self-efficacy plays important roles in people’s lives 
(Bandura 1994; Delbaere and Willis 2015; Ritter and Lorig 2014). Bandura (1994) 
defines self-efficacy as “people’s beliefs about their capabilities to produce designated 
levels of performance that exercise influence over events that affect their lives” (p 2). 
Interaction with support groups online and membership in covert brand communities may 
be a source of perceived influence over community members’ own disease self-
management. Self-efficacy of managing a chronic illness is also a predictor of future 
behaviour (Bandura 1994; Ritter and Lorig 2014). A Self-Efficacy for Managing Chronic 
Disease scale was also adapted from Ritter and Lorig (2014), and Delbaere and Willis 
(2015), to measure participants’ beliefs that being an active member of this community 
can help manage symptoms related to their chronic illness (Appendix P Question 14). 
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A brand evaluation measure of Pfizer was also included in the measurements to analyze 
how participants perceived Pfizer and whether this influenced the results. Manipulation 
checks were included for community sponsorship, presence of logo, and group 
membership. Frequency of social media use and online health information use, and 
demographic information were also measured. (See Appendix P for questionnaire) 
 
4.3 RESULTS 
A total of 165 participants from across Canada who had been diagnosed with Type II 
diabetes participated in our online study. In order to participate in this experiment, 
respondents had to indicate whether they had been diagnosed with Type II Diabetes. If 
they did not report a diagnosis, these people were screened out and did not complete the 
study. All participants reported being highly familiar with Type II Diabetes (M = 6.11, on 
a 7-point scale), and this did not differ between conditions (p > 0.05). Participants ranged 
in age from 28-84 years old (M age = 60.84, 6.7% preferred not to report their age) and 
46.1% of the respondents were female (0.6% other, 0.6% preferred not to say). 66.9% of 
the participants in the study reported using social media at least once a day, 20% once a 
month or less, and 13.9% reported never using social media. A majority of the 
participants (86.1%) reported going online for health information, 26.7% reported 
visiting an online support group, and 12.7% of participants had joined an online support 
group. 
 
Participants spent an average of 12.11 minutes completing our questionnaire, the 
minimum time spent on the questionnaire was 4.38 minutes, and the maximum was 37.4 
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minutes. In our open-ended responses, participants averaged 1.67 thoughts per person, 
the minimum number of thoughts was 1, and the maximum was 6 thoughts. Participants’ 
knowledge towards Pfizer, and attitudes towards Pfizer were not significantly different 
across groups (p > 0.05) indicating that our manipulations did not influence peoples’ 
views or knowledge of Pfizer.  
 
A factor analysis of the scale measures revealed that the adapted agreement statements 
from Wang et al (2008), which were our second persuasion knowledge measure, had 
scale items that were highly correlated with two other measures. The first two scale items 
(Appendix P Questions 4a and 4b) were correlated with our first PK measure of 
scepticism from Campbell and Kirmani (2000) and the last two items (Appendix P 
Questions 4c and 4d) were correlated with Huh and Shin’s (2014) perceived website trust 
scale.  
 
The first two items of the agreement statements measured credibility and accuracy of 
information, which have also been used as measurements of persuasion knowledge (Ham, 
Nelson and Das 2015; Hibbert, Smith, Davies, and Ireland 2007; Isaac and Grayson 
2016). Because measurements of PK often measure many related dimensions such as 
skepticism, credibility, manipulative intent, believability, deceptiveness, etc. (Ham, 
Nelson and Das 2015), the addition of two more relevant scale items was an appropriate 
solution. Therefore, when analyzing PK activation we combined the first two items of 
Wang et al’s (2008) agreement statements measuring credibility and accuracy of 
information (Appendix P Question 4a and 4b) with Cambpell and Kirmani’s (2000) PK 
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measure of scepticism (Appendix P Question 3) to overcome this problem. All 
subsequent analyses used this combined measure for PK activation. 
 
The last two items of the agreement statements measured trust in the information in the 
community (Appendix P Question 4c), and trust in the people in the community 
(Appendix P Question 4d), which were highly correlated with Huh and Shin’s (2014) 
perceived website trust measure (Appendix P Questions 5-11), which was already being 
used. To fix this issue, the two items from the second persuasion knowledge measure 
were combined with their more appropriate measures of perceived website trust, and the 
second PK measure was not used in the analyses.  
 
A scale reliability analysis was then conducted on each updated measure to ensure all 
scales items measured what they were supposed to. This analysis revealed a high 
Cronbach’s Alpha for each measure (α Combined PKA = 0.914, α Combined Trust = 0.969, α Intent = 
0.928, α Self Efficacy = 0.927). 
 
When asked what participants believed the purpose of the group was, 24.2% believed it 
was for general health promotion, awareness, and education; 20.6% believed the 
community was for community member support, 18.8% did not know what the purpose 
was; 17.6% believed it was to connect people who had been affected by the illness and 
share information and stories; and 12.7% thought it was for pharmaceutical promotion or 
research. 
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Two independent coders analyzed the open-ended responses from all participants. All 
disagreements were resolved through discussion. Cohen’s Kappa was calculated to 
determine inter-rater reliability and revealed a high level of inter-rater agreement (κ = 
0.949). An independent samples Kruskal-Wallis test was used to analyze mean 
differences in total number of thoughts per group. This test showed that there was no 
significant difference in number of unique thoughts per group (M Prime/Logo = 1.33, M 
Prime/No Logo = 1.76, M No Prime/Logo = 1.76, M No Prime/No Logo = 1.84, p = 0.106).   
 
Our manipulation checks confirmed that significantly more people reported seeing a logo 
in the Pfizer condition versus in the no logo condition (p = 0.003); therefore we can 
conclude there was a successful logo manipulation. The membership manipulation 
yielded a mean value near the midpoint of the scale (M membership = 3.085), indicating no 
extreme feeling for, or against, membership in the community. This was expected, as 
participants only viewed screenshots of a community, rather than interacting, liking, 
sharing, or posting within the community, which may yield higher feelings of 
membership.  
 
Our second manipulation checks looked at participant skepticism using ratio of 
suspicious thoughts to total thoughts per condition, and Campbell and Kirmani’s (2000) 
PK measure between the prime conditions. A one-way ANOVA was conducted to 
analyze the ratio of suspicious thoughts per condition and found no significant mean 
differences in suspicious thoughts per condition (M Prime/Logo = 0.3095, M Prime/No Logo = 
0.3895, M No Prime/Logo = 0.3415, M No Prime/No Logo = 0.3087, p > 0.05). Our analysis of the 
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persuasion knowledge activation scale items found that when primed for PK, participants 
were more sceptical of the covert brand community (M Prime = 4.408), versus when they 
were not primed (M No Prime = 4.852, p = 0.043), indicating the activation of persuasion 
knowledge. Though there was no difference in suspicious thoughts per condition, our 
scale item identified persuasion knowledge activation, which signals a successful 
manipulation. 
 
To test hypothesis 1 and 2, a moderated-mediation analysis was conducted using Hayes’ 
PROCESS procedure for SPSS. The analysis was set up to test the moderating 
(conditional) effects of the presence or absence of branding cues on the mediating 
(process) effect of persuasion knowledge activation. The analysis revealed a non-
significant moderating effect of the logo condition and mediating effect of persuasion 
knowledge activation on perceived trust (p > 0.05, CI [-0.0346, 0.1551]), and behavioural 
intentions (p > 0.05, CI [-0.1038, 0.1459]). This non-significant result indicates that 
Hypotheses 1 and 2 are not supported, as there were no intervening effects of presence of 
logo on evaluations or behavioural intentions (See Figure 4.2 and 4.3, and Table 4.1).  
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Figure 4.2 
Mediated-Moderation Analysis for Perceived Website Trust 
 
 
 
 
Figure 4.3 
Mediated-Moderation Analysis for Intent to use Information 
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Table 4.1  
Descriptive Statistics for group differences with PK activation 
Measure Condition Mean SD 
Logo 3.87 1.48 
No Logo 3.50 1.55 
Logo 3.28 1.64 
No Logo 3.12 1.64 
Logo 4.08 2.16 
No Logo 4.07 2.44 
 
This result is consistent with our findings from study 1, and the findings of Wojdynski 
and Evans’ (2015) study on native advertising. The presence of branding cues did not 
influence participant evaluations, which lends further support to the logic that consumers 
do not view covert brand communities as persuasion attempts. The results from this study 
address concerns about the undergraduate population that was being tested in our first 
study, by showing the same results in an older population that has been diagnosed with 
Type II diabetes.  
 
To test Hypothesis 3 an ANOVA was conducted on participants whose PK was not 
activated. This analysis found no differences on perceived website trust (M Logo = 4.640, 
M No Logo = 4.283, p = 0.285), Intent to use Information (M Logo = 3.976, M No Logo = 3.833, 
p = 0.704), and self-efficacy (M Logo = 4.821, M No Logo = 4.75, p = 0.889). This finding, 
which is consistent with study 1, shows support for Hypothesis 3 (See Table 4.2). 
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Table 4.2  
Descriptive Statistics for group differences with no PK activation 
Measure Condition Mean SD 
Logo 4.66 1.39 
No Logo 4.31 1.70 
Logo 3.98 1.73 
No Logo 3.83 1.71 
Logo 4.82 2.20 
No Logo 4.75 2.46 
 
Interestingly, participants’ perceived self-efficacy for managing their symptoms was 
marginally significant between the prime conditions (p = 0.051). Participants in the prime 
condition reported lower self-efficacy for managing their symptoms versus in the no 
prime condition (M Prime = 4.075, M No Prime = 4.786). 
 
In order to achieve the main objective of our study, which was to answer our second 
research question— does activating persuasion knowledge influence member evaluations 
of, and intentions to use, information in Facebook health and wellness communities? — 
several mediation analyses were conducted. The mediation analyses were carried out 
using Hayes’ PROCESS procedure for SPSS as recommended by Field (2013).   
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This first analysis showed a non significant indirect (process) effect of priming on 
perceived trust through persuasion knowledge activation (b Indirect_Trust = 0.3750, CI [-
0.0053, 0.7348]), and a significant direct effect of priming on perceived trust (b Direct_Trust 
= 0.3882, CI [0.0986, 0.6779]) which represents a small effect size (r2 = 0.0448, 95% CI 
[0.0008, 0.1240] See Figure 4.4). 
 
Figure 4.4 
Mediation Analysis for Perceived Website Trust 
 
The second mediation analysis revealed a fully mediated and significant indirect effect on 
intent to use information through persuasion knowledge activation (b Intent = 0.3376, CI 
[0.0160, 0.6877]). This effect represents a small effect size (r2Intent = 0.0311, 95% CI 
[0.0007, 0.0955] See Figure 4.5). 
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Figure 4.5 
Mediation Analysis for Intent to use Information 
 
Further examination of the relationships between persuasion knowledge, trust, and 
behavioural intentions led us to conduct an additional mediation analysis to see if 
perceived trust, in addition to persuasion knowledge activation, influenced peoples’ intent 
to use the information on the Facebook community. This exploration was designed as a 
double mediation analysis to test if both persuasion knowledge activation and perceived 
website trust mediated the relationship between priming for persuasion knowledge and 
behavioural intent. This analysis showed a significant fully mediated indirect effect of 
priming on behavioural intention through persuasion knowledge activation and perceived 
trust (b indirect = 0.3551, 95% CI [0.0109, 0.7131]).  The multiple mediation analysis also 
showed a significant path of priming on intent to use information through perceived trust 
(b Indirect trust = 0.3676, 95% CI [0.1006, 0.6540]).  (See Figure 4.6) 
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Figure 4.6 
Mediation Analysis for multiple mediators 
 
Taken together, these results answer our second research question and show that 
perceived trust and persuasion knowledge activation both play important roles in 
determining if people will use the information on a covert brand community. When 
participants’ PK is activated, people are more skeptical (M Prime = 4.408, M No Prime = 
4.852, p = 0.043), and as a result they trust the community less (M Trust/Prime = 3.683, M 
Trust/No Prime = 4.461, p = 0.001), and have lower intentions to use the information in the 
covert brand community (M Intent/Prime = 3.200, M Intent/No Prime = 3.904, p = 0.008). 
Therefore we can conclude that activating persuasion knowledge does influence 
evaluations and behavioural intentions in Facebook health and wellness communities.  
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4.4 DISCUSSION  
The results from study 2 show that persuasion knowledge is activated when using a 
prime, and influences peoples’ perceived trust of the covert brand community and 
behavioural intentions toward the information in the covert brand community. These 
results show that though participants had identified the logo on the Facebook page, this 
had no significant effect on their evaluations or intentions. This is particularly interesting 
because it shows that the presence of branding cues will not significantly impact peoples’ 
perceived trust of the covert brand community, or their intentions to use the information 
presented in the community.  
 
This study further supports the idea that covert tactics will go unrecognized by consumers 
(Fransen et al 2015; Laran, Dalton, and Andrade 2011). This research also tests the long 
held assumption that priming persuasion knowledge leads to differences in evaluations 
and intentions. Our findings show that the relationship between a prime and differences 
in evaluations is mediated by the activation of PK. This result shows that the prime is not 
the reason why consumers have differences in evaluations and intentions; the prime 
activates a consumer’s PK, which is the reason for difference in evaluations and 
intentions. This important relationship needs to be taken into consideration in the 
planning of future research involving priming for PK. 
 
The use of real screenshots from an actual covert brand community and an actual 
pharmaceutical brand was to increase the realism of the stimuli in the experiment 
(Delbaere and Willis 2015). One limitation of this study is that participants could not 
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interact with the covert brand community; they were only able to view a screenshot of the 
community before answering questions. It is likely that evaluations of the community 
would be positive if participants were able to join and interact with the community over a 
period of time.  
 
We speculate that evaluations would be more positive because of the impact of factors 
such as bonding and homophily have on consumers’ experiences in online communities 
(Chu and Kim 2011; Scott Rader et al 2013; Wang et al 2008). Wang et al’s (2008) study, 
which looked at health information online and peer-to-peer influence on websites versus 
discussion groups, measured the impact of variables like homophily on the perceived 
credibility and the evaluation of the health information. Homophily is described as “the 
degree of perceived similarity a receiver ascribes to a message source” (Wang et al 2008, 
p 359). In a setting such as a covert brand community where most of the community 
members have shared experiences with a chronic illness it is likely that members would 
have higher levels of homophily because of the perceived similarity of experience with 
their peers (Scott Rader et al 2013). Interestingly, the authors found that participants with 
higher levels of homophily had more positive evaluation of the health information, and 
were therefore more likely to act on it (Wang et al 2008). This finding leads us to 
speculate that studying members of a covert brand community who had interacted with 
the community over time will have higher evaluations. 
 
Because this research showed no significant effect of branding, future research should 
also prime for branding, or test to see if the source of the information i.e. recommended 
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by a doctor, will change peoples’ evaluations. Future studies should continue to analyze 
Covert Brand Communities by exploring recent developments in this area concerning 
sponsorship transparency (Wojdynski, Evans, and Hoy 2017), and perceived tactic 
appropriateness (Isaac and Grayson 2016).  
 
Another limitation that could have influenced the results in both studies is the language 
used in the script that preceded the stimuli, which asked participants to imagine they were 
members of the Facebook community. We recognize that “giving” participants 
membership to these communities before viewing the stimuli could have made them feel 
invested in the group, and therefore may have resulted in demand effects in participants’ 
evaluations. Evaluations may have been less favourable if participants had been 
instructed to imagine they had been recently diagnosed and were looking for 
communities to join, rather than to imagine they were already members of the 
community.  In order to address this limitation, future research should expand on these 
findings to examine whether group membership plays a factor in influencing consumers’ 
attitudes and PK activation in these covert settings. Researchers should also look into the 
role that age plays in PK activation; older consumers have likely been exposed to more 
health issues than younger consumers and this could lead to a heightened sensitivity to 
persuasion attempts in this domain.  
 
These results are also important for concerns about the large gap in regulation 
surrounding media that facilitate consumer-to-consumer communication, and the 
accuracy of drug claims and influence of disease education on social media. With much 
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of these activities still unregulated, it is important that we take a deeper look into what 
regulation is required to protect consumers. The potential consequences of leaving these 
channels unrestricted are dangerous from an ethical standpoint, because as we have seen, 
consumers do not recognize pharmaceutical companies’ persuasion attempts on these 
media channels.  
 
Future research should also give more attention to the co-branding aspect of 
pharmaceutical marketing that was briefly addressed in our first study. Looking at the 
dynamics of persuasion knowledge between pharmaceutical organizations and third party 
groups like the American Diabetes Association would provide interesting insight for 
theory and practice. 
 
5. CONCLUSION 
Overall, this research shows that unless primed to be thinking about persuasion attempts, 
consumers do not recognize Covert Brand Communities as persuasion attempts, even 
with the presence of branding cues. These results are consistent with Fransen et al’s 
(2015), Laran, Dalton, and Andrade’s (2011), and Wojdynski and Evans’ (2015) view 
that covert attempts go largely unnoticed. This research also shows that evaluations and 
intentions of covert attempts are mediated by a consumer’s persuasion knowledge 
activation.  
 
This has several implications for theory, practice, and policy. Concerning theory, the 
findings from these studies add valuable insight to the area of covert pharmaceutical 
 46 
marketing. As Huh and Shin (2015) have highlighted, consumers today are more active 
and engaged in obtaining health information online, making it important to research the 
ways pharmaceutical companies are utilizing their online marketing tools and their 
effects on consumers. Without explicit transparency of the community sponsor, or 
without persuasion knowledge activation, consumers are more trusting and have higher 
intentions of using the information from covert brand communities versus when their 
knowledge of persuasion is activated. For future research in the area of covert marketing 
and PK, our results show the important indirect relationship between priming, PK 
activation, and evaluations and intentions. This relationship needs to be incorporated into 
future experiment and manipulation design, and model development when looking at 
differences in evaluations due to a prime for PK.  
 
For practice, this research confirms the idea that covert brand communities can be used as 
a way to increase consumer evaluations and behavioural intentions by avoiding 
consumers’ persuasion resistance strategies. Ethically however, one needs to consider if 
the use of these tactics for pharmaceutical organizations falls in line with the AMA’s 
code of conduct for marketers. This ethical code of conduct states that marketers should 
avoid “harmful actions or omissions by embodying high ethical standards and adhering to 
all applicable laws and regulations” and we should also avoid “deception in product 
design, pricing, communication, and delivery of distribution” (ama.org). The use of this 
tactic also violates Laczniak and Murphy’s (2006) principle of nondeception which states 
“marketers ought to never intentionally mislead or unfairly manipulate consumers” (p 
165). 
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Though the use of this tactic has no clear policy guidelines, there is a distinct omission 
being made by pharmaceutical companies who do not clearly disclose their involvement 
with these covert brand communities. This distinct omission is also something that the 
FTC would consider deceptive marketing: “regardless of the medium in which an 
advertising or promotional message is disseminated, deception occurs when consumers 
acting reasonably under the circumstances are misled about its nature or source, and such 
misleading impression is likely to affect their decisions or conduct regarding the 
advertised product or the advertising” (FTC 2015). 
 
As Laczniak and Murphy (2006) explain in their guiding article on marketing ethics, 
“…organizations always should strive to exceed the legal minimums of social 
compliance” (p 159). They further describe how ethics undertakes greater duties and 
obligations than just following the minimum required laws, and argue that even the 
AMA’s code of ethics are simply the basic criteria of what society expects of marketers. 
Rather than operating in a grey area of regulation, especially in the pharmaceutical 
domain, marketers need to go beyond the required legal minimums and refrain from what 
Laczniak and Murphy (2006) would consider a “socially troubling marketing practice” (p 
159). 
 
With that being said, these finding also raise an important policy issue: should online 
pharmaceutical marketing—which has fewer regulations—have more explicit disclosure 
of involvement and sponsorship? Because a potential disclosure may activate consumers’ 
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suspicion, this may result in lower evaluations and behavioural intentions as our research 
has shown. However, if no disclosure is present, as we have seen, consumers will not 
recognize these tactics as persuasion attempts even if branding cues are present. 
 
Though most of the points raised have been critical of covert brand communities, there 
are several positive outcomes of these groups for both the company and the consumer. 
Pharmaceutical companies benefit from this tactic by facilitating greater two-way 
communication with their target audiences. This can be an effective way of establishing a 
relationship with consumers, developing goodwill for the pharmaceutical brand, 
communicating disease and treatment knowledge, and eventually increasing sales (Scott 
Rader et al 2013). Pharmaceutical companies also have the ability to influence the 
content, information, and dialogue that occurs within their community, which allows 
them to better follow regulation, and to direct consumer conversations. 
 
Ethical considerations aside, covert brand communities do provide value for their 
members. These communities consolidate and link to disease and symptom treatment 
information that has value for people who are affected by an illness. These communities 
are also a platform for people who are seeking information, sharing information, or 
sharing their experiences with others who have had similar experiences, and seek 
emotional support (Johnson and Lowe 2015; Scott Rader et al 2013). Often, consumers 
experiencing similar health related challenges would view themselves as an in-group, and 
bond as members of a community (Johnson and Lowe 2015). Accordingly, one of the 
sources of cocreated value in these communities is the consumer bonding—the 
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connection to the community and the unity among members—that happens in a covert 
brand community (McAlexander, Schouten, and Koenig 2002; Muniz and O’Guinn 2001; 
Scott Rader et al 2013). 
 
In conclusion, the studies presented here test competing theories and assumptions of 
covert marketing and persuasion knowledge in the context of pharmaceutical covert 
brand communities. Extending Huh and Shin’s (2015) research on pharmaceutical DTC 
websites, this research explores an area of Scott Rader et al’s (2013) model (Figure 1.1) 
that has been largely overlooked by research—social media use by pharmaceutical 
companies. Most research has looked at company-controlled websites, but none have 
looked at company-sponsored communication on social media platforms where 
regulations are less clear. This research is a first step into this area, which is an important 
tool used in combination with company controlled websites. Future research should 
explore the other areas identified by Scott Rader et al (2013) beyond Facebook, such as 
Twitter, online forums, and blogs. 
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Appendices 
Appendix A – Ethics Approval 
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Appendix B – Ethics Amendment 
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Appendix C – Study 1 Participant Consent Form 
 
You are invited to participate in a research study entitled:  
“Social Media Health and Wellness Study”       
Researcher(s): Adam Slobodzian, Graduate Student. Edwards School of Business. 
adam.slobodzian@usask.ca  
Supervisor:  Dr. Marjorie Delbaere, Department of Management and Marketing, 
Edwards School of Business. 306-966-5916 delbaere@usask.ca  
If you have any questions or concerns please contact one of the researchers. 
 
Purpose and Objectives of the Research:  
• The aim of the study is to gain insight into the effectiveness of social media health and 
wellness communities.  
Procedures:  
• You will be asked to first read a scenario and then a social media post. 
• After reading both the scenario and the post, you will be asked to answer a 
questionnaire about what you have read, which should take approx. 10-15 minutes to 
complete. 
• Please feel free to ask any questions regarding the procedures and goals of the study.  
Potential Risks 
• There are no known or anticipated risks to you by participating in this research. 
Compensation:  
• To thank you for your time, please help yourself to some Halloween treats on your 
way out. 
Confidentiality:  
• You will not be asked to provide any identifying information on the questionnaire, and 
your data will be treated as confidential. There may be limits to confidentiality, 
however, due to the group setting of this study.  The researchers and participants may 
therefore be aware of the identities of the other participants in the study. 
• Although the data from this research project will be published and presented at 
conferences, the data will be reported in aggregate form, so that it will not be possible 
to identify individuals.  Please do not put your name or other identifying information 
on the questionnaire. 
• All data will be stored in a locked office on campus and on a password-protected 
server maintained by the University of Saskatchewan; only the research team will 
have access to the files. Once the data is no longer needed it will be shredded in a 
secure facility. 
Right to Withdraw 
• Your participation is voluntary and you can answer only those questions that you are 
comfortable with.  You may withdraw from the research project for any reason, at 
any time without explanation or penalty of any sort.  
• Should you wish to withdraw your academic status in this course will not be 
affected. 
• Should you wish to withdraw it will not be possible to remove your data once it has 
been submitted to the researcher, as no identifying information will be recorded on 
the questionnaire. 
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Follow up:  
• At the end of this study the research will be used and reported in the master’s thesis 
of Adam Slobodzian. To obtain results of the study please contact one of the 
researchers. 
• This research may also be reported in the form of an academic journal article and an 
academic conference presentation. 
• This research project has been approved on ethical grounds by the University of 
Saskatchewan Research Ethics Board.  Any questions regarding your rights as a 
participant may be addressed to that committee through the Research Ethics Office 
ethics.office@usask.ca (306) 966-2975. Out of town participants may call toll free 
(888) 966-2975. 
 
Consent  
By completing and submitting the questionnaire, your free and informed consent is 
implied and indicates that you understand the above conditions of participation in this 
study. 
A copy of this consent will be left with you. 
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Appendix D – Study 1 Recruitment Poster 
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Appendix E – Script Study 1  Imagine that you’ve recently been diagnosed with [Disease]. Your doctor has recommended a course of treatment that you are following, but you are still left with unanswered questions about the disease, how it will impact your life and where to get support. Following your diagnosis, you joined an online health and wellness community on Facebook called [Community] that is made up of members like you who are all affected in some way by this disease.  This community regularly posts information about living with the disease, support, lifestyle and exercise routines, contests for giveaways, and suggestions for how to manage the disease yourself. You are not sure who has created this group but there are many active members who have become very close because of this community.   You are an active member of this community and you often read, share, and like the published posts, and interact with other members.   Flip to the next page and imagine that you are viewing recent posts from this community. 
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Appendix F – Study 1 Stimuli: Logo Condition 
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Appendix G – Study 1 Stimuli: No Logo Condition 
 
  
 59 
  
 60 
Appendix H – Study 1 Stimuli: Third Party Condition 
 
 
  
 61 
  
 62 
Appendix I – Study 1 Questionnaire 1) Please list any thoughts and feelings you experienced while reading the Facebook page. Write each thought on a separate line. a)  ______________________________________________________________________________________ b)  ______________________________________________________________________________________ c)  ______________________________________________________________________________________ d)  ______________________________________________________________________________________ e)  ______________________________________________________________________________________ f)  _____________________________________________________________________________________ 2) What do you believe is the purpose of this Facebook community?   3) Please rate this Facebook Community on the following dimensions: Insincere 1 2 3 4 5 6 7 Sincere Dishonest 1 2 3 4 5 6 7 Honest Manipulative 1 2 3 4 5 6 7 Not manipulative Pushy 1 2 3 4 5 6 7 Not pushy  4) Rate your agreement with the following statements: a) This Facebook Community is credible. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  b) The information on this Facebook Community is accurate. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  c) I can trust the information and people in this Facebook Community. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  d) While I viewed the Facebook page, it was pretty clear that the page was trying to influence my behavior. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  5) Overall, this Facebook community is probably an excellent health information 
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provider.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  6) I expect this Facebook community to perform its role of giving health information very effectively.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  7) In general, this Facebook community is probably well qualified to provide health information and advice.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  8) This Facebook community would probably be honest in how it deals with me.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  9)  Overall, I expect this Facebook community to be truthful.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  10) I anticipate that this Facebook community would provide me factual information.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  11) This Facebook community would probably honor any commitments it makes. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  12) Please answer the following questions about yourself:    a) Age (in years): ______ b) Gender:  ☐Female 
☐Male 
☐Other _____________________________________ 
☐Prefer not to say  
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13) How familiar are you with [disease]? Not at all familiar 1 2 3 4 5 6 7 Very familiar  14) Have you ever gone online for health information?  
☐Yes  ☐No a) If yes, which sites have you consulted? 
☐ Webmd 
☐ Facebook 
☐ Google 
☐ Health Canada 
☐ PubMed 
☐ cdc.com 
☐ myfitnesspal.com 
☐ drugs.com 
☐ medscape 
☐ weightwatchers.com 
☐ Other (please specify): __________________________ 15) Was there a logo on the [Community] Facebook page?     
☐Yes  ☐No a)  If Yes, which organization’s logo? ___________________________________ 16) Who do you think the sponsor of the community is? ____________________________________________________________  17) How familiar are you with the organization represented by the logo?  Not at all familiar 1 2 3 4 5 6 7 Very familiar  18) Were you aware of this Facebook community prior to the study?     
☐Yes  ☐No  
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Appendix J – Study 2 SSRL Participant Consent Message 
            
 
Title: Social Media Health and Wellness Study 
 
This survey is designed to help us understand Social Media Health and Wellness 
Communities on Facebook.  This information will help to identify people’s perceptions 
regarding this topic.  Participation in this survey is voluntary, and you can decide not to 
participate at any time, or choose not to answer any questions you don’t feel comfortable 
with.  Survey responses will remain anonymous. Since the survey is anonymous, once it 
is submitted it cannot be removed.  
  
There are no known risks to participating in this survey; however, as with any online 
related activity the risk of breach of confidentiality is always possible.  
 
This survey is hosted by Voxco, a Canadian-owned and managed company whose data is 
securely stored in Canada. Please consider printing this page for your records. 
This research project has been approved on ethical grounds by the University of 
Saskatchewan Research Ethics Board.  Any questions regarding your rights as a 
participant may be addressed to that committee through the Research Ethics Office 
ethics.office@usask.ca; (306) 966-2975. Out of town participants may call toll free (888) 
966-2975. 
 
In order to complete this survey, you may be required to answer certain questions; 
however, you are never obligated to respond and you may withdraw from the survey at 
any time by closing your internet browser. 
 
By selecting next and completing this questionnaire, your free and informed consent is 
implied and indicates that you understand the above conditions to participate in this 
study. 
 
Completion of the survey should take approximately 15 minutes.   
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Appendix K – Study 2 SSRL Recruitment Email 
 
Dear member of the Ekos research panel, 
 
You are invited to participate in a survey on social media health and wellness 
communities. This is an ethics-approved, University of Saskatchewan research project 
looking to gain insight into the effectiveness of social media health and wellness 
communities. 
 
Please rest assured that this is voluntary and your answers are completely confidential 
(this means that no individual will be associated with the survey's results - rather, all of 
the results will be combined to protect the confidentiality of each respondent). 
 
The researchers at the University of Saskatchewan would like to thank you for your 
interest in their research and your participation. 
 
Ekos, Inc. 
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Appendix L – Script Study 2  Following your diagnosis of Type II Diabetes, imagine you have joined an online health and wellness community on Facebook called Diabetes Challenge that is made up of members like you who are all affected in some way by this disease.  This community regularly posts information about living with the disease, support, lifestyle and exercise routines, contests for giveaways, and suggestions for how to manage the disease yourself. There are many active members who have become very close because of this community.   Please imagine you are an active member of this community and you often read, share, and like the published posts, and interact with other members.   Proceed to the next page and imagine that you are viewing recent posts from this community. 
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Appendix M – Prime 
 
Please keep in mind that sometimes consumers create these types of communities. Other 
times pharmaceutical companies create these communities, both to help consumers as 
well as to help their business. Sometimes the companies indicate their involvement with 
the online communities, and sometimes they do not. 
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Appendix N – Study 2 Stimuli: No Logo Condition 
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Appendix O – Study 2 Stimuli: Pfizer Condition 
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Appendix P – Study 2 Questionnaire 1) Please list any thoughts and feelings you experienced while reading the Facebook page. Write each thought on a separate line. a)  ______________________________________________________________________________________ b)  ______________________________________________________________________________________ c)  ______________________________________________________________________________________ d)  ______________________________________________________________________________________  2) What do you believe is the purpose of this Facebook Community?   3) Please rate this Facebook Community on the following dimensions: Insincere 1 2 3 4 5 6 7 Sincere Dishonest 1 2 3 4 5 6 7 Honest Manipulative 1 2 3 4 5 6 7 Not manipulative Pushy 1 2 3 4 5 6 7 Not pushy  4) Rate your agreement with the following statements: a) This Facebook Community is credible. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  b) The information on this Facebook Community is accurate. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  c) I can trust the information in this Facebook Community. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  d) I can trust the people in this Facebook Community. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  5) Overall, this Facebook community is probably an excellent health information provider.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
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 6) I expect this Facebook community to perform its role of giving health information very effectively.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  7) In general, this Facebook community is probably well qualified to provide health information and advice.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  8) This Facebook community would probably be honest in how it deals with me.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  9)  Overall, I expect this Facebook community to be truthful.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  10) I anticipate that this Facebook community would provide me factual information.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  11) This Facebook community would probably honor any commitments it makes. Strongly disagree 1 2 3 4 5 6 7 Strongly agree  12) Assuming the Diabetes Challenge Facebook community was available for you to access, please rate your level of agreement with each statement.  i. I would visit this community again to get information: Strongly disagree 1 2 3 4 5 6 7 Strongly agree  ii. I would depend on the information or advice provided by this Facebook Community: Strongly disagree 1 2 3 4 5 6 7 Strongly agree  
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iii. I would recommend this Facebook Community to a friend or family member: Strongly disagree 1 2 3 4 5 6 7 Strongly agree  iv. I would comment on posts from this Facebook Community: Strongly disagree 1 2 3 4 5 6 7 Strongly agree  v. I would share posts from this Community on my Facebook wall: Strongly disagree 1 2 3 4 5 6 7 Strongly agree  vi. I would talk to my doctor about information from this Community: Strongly disagree 1 2 3 4 5 6 7 Strongly agree  13) Who do you think the sponsor of the community is? ____________________________________________________________ 14) To what extent do you think being an active member of a community like 
Diabetes Challenge could help you to manage the following symptoms and health problems caused by diabetes?: 
 Fatigue: 
Not at all 
Confident 1 2 3 4 5 6 7 8 9 10 
Totally 
Confident  
 Physical discomfort or pain: 
Not at all 
Confident 1 2 3 4 5 6 7 8 9 10 
Totally 
Confident  
 Emotional distress: 
Not at all 
Confident 1 2 3 4 5 6 7 8 9 10 
Totally 
Confident  
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15) Was there a company’s logo on the [Community] Facebook page? (Other than the Facebook logo)    
☐Yes  ☐No a)  If Yes, which company’s logo? ___________________________________ b) How familiar are you with the organization represented by this logo?  Not at all familiar 1 2 3 4 5 6 7 Very familiar  16) Please answer the following questions about yourself:    a) Age (in years): ______ b) Gender:  ☐Female 
☐Male 
☐Other _____________________________________ 
☐Prefer not to say 17) How familiar are you with diabetes? Not at all familiar 1 2 3 4 5 6 7 Very familiar  18) Have you ever gone online for health information?  
☐Yes  ☐No 19) How often do you go online for health information? (Please check the box that best describes your average usage frequency) 
☐ Multiple times daily 
☐ Once a day 
☐ Less than once a week 
☐ Less than once a month 
☐ Never  20) Have you ever consulted a Facebook page for health information?  
☐Yes  ☐No 21) How often do you use social media? (Please check the box that best describes 
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your average usage frequency) 
☐ Multiple times daily 
☐ Once a day 
☐ Less than once a week 
☐ Less than once a month 
☐ never 22) Please give your opinion about the company Pfizer by answering the following questions.  a) Pfizer is: Not at all trustworthy 1 2 3 4 5 6 7 Very trustworthy Not at all honest 1 2 3 4 5 6 7 Very honest Cares more about making money 1 2 3 4 5 6 7 Cares more about helping customers  b) Compared to the average consumer, how knowledgeable are you about Pfizer? Significantly less knowledgeable 1 2 3 4 5 6 7 Significantly more knowledgeable  23) Please rate your agreement with this statement: When viewing this Facebook page, I felt as though I was a member of the community.  Strongly disagree 1 2 3 4 5 6 7 Strongly agree  24) Were you aware of this Facebook community prior to the study?     
☐Yes  ☐No  
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